US Patent Litigations are now available. Check here

Explore Adare Pharmaceuticals's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Patent NumberGrant DateTitleTotal Oppositions
EP3041476Jan 25, 2023Corticosteroid Containing Orally Disintegrating Tablet Compositions For Eosinophilic Esophagitis2
EP2646003Jun 3, 2020Rapidly Dispersing Granules, Orally Disintegrating Tablets And Methods1
EP3403654Jul 31, 2019Orally Administered Corticosteroid Compositions2
EP2482822Aug 1, 2018Orally Administered Corticosteroid Compositions2